Cofactor closes the precision medicine gap with predictive diagnostics Cofactor Genomics is a biotechnology company pioneering the use of RNA to diagnose disease. The company’s novel technology combines biology with proprietary machine learning software to develop unique molecular diagnostics centered on RNA. Cofactor Genomics was founded by three former Human Genome Project molecular and computational scientists and is dual headquartered in St. Louis, MO and San Francisco, CA. To date, Cofactor Genomics has raised more than $20 million in funding, including an oversubscribed $18 million Series A in 2017. The company is backed by several top-tier investors including Menlo Ventures, Data Collective, Y Combinator, Ascension Ventures, Wilson Sonsini Goodrich & Rosati, and Stanford University, among others. Cofactor has been featured in many publications, including TechCrunch and Wired Magazine.